ID   CLK3_HUMAN              Reviewed;         638 AA.
AC   P49761; D3DW59; Q53Y48; Q9BRS3; Q9BUJ7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 3.
DT   15-MAR-2017, entry version 178.
DE   RecName: Full=Dual specificity protein kinase CLK3;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 3;
GN   Name=CLK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=7990150; DOI=10.1006/jmbi.1994.1763;
RA   Hanes J.J., der Kammer H., Klaudiny J.J., Scheit K.H.;
RT   "Characterization by cDNA cloning of two new human protein kinases.
RT   Evidence by sequence comparison of a new family of mammalian protein
RT   kinases.";
RL   J. Mol. Biol. 244:665-672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 137-638 (ISOFORM 4).
RC   TISSUE=Cervix, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=9637771; DOI=10.1006/excr.1998.4083;
RA   Duncan P.I., Stojdl D.F., Marius R.M., Scheit K.H., Bell J.C.;
RT   "The Clk2 and Clk3 dual-specificity protein kinases regulate the
RT   intranuclear distribution of SR proteins and influence pre-mRNA
RT   splicing.";
RL   Exp. Cell Res. 241:300-308(1998).
RN   [7]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-155; SER-157; SER-224
RP   AND SER-226, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/CIRCRESAHA.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative
RT   splicing of tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215; SER-224 AND
RP   SER-226, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-197; SER-199
RP   AND SER-283, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF 284-638.
RA   Papagrigoriou E., Rellos P., Das S., Ugochukwu E., Turnbull A.,
RA   von Delft F., Bunkoczi G., Sobott F., Bullock A., Fedorov O.,
RA   Gileadi C., Savitsky P., Edwards A., Aerrowsmith C., Weigel J.,
RA   Sundstrom M., Knapp S.;
RT   "Crystal structure of CLK3.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 275-627.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the phosphorylated clk3.";
RL   Submitted (APR-2007) to the PDB data bank.
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 275-632 IN COMPLEX WITH
RP   LEUCETTINE L41.
RX   PubMed=21615147; DOI=10.1021/jm200274d;
RA   Debdab M., Carreaux F., Renault S., Soundararajan M., Fedorov O.,
RA   Filippakopoulos P., Lozach O., Babault L., Tahtouh T., Baratte B.,
RA   Ogawa Y., Hagiwara M., Eisenreich A., Rauch U., Knapp S., Meijer L.,
RA   Bazureau J.P.;
RT   "Leucettines, a class of potent inhibitors of cdc2-like kinases and
RT   dual specificity, tyrosine phosphorylation regulated kinases derived
RT   from the marine sponge leucettamine B: modulation of alternative pre-
RT   RNA splicing.";
RL   J. Med. Chem. 54:4172-4186(2011).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-486; ARG-607 AND TRP-628.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine
CC       and tyrosine-containing substrates. Phosphorylates serine- and
CC       arginine-rich (SR) proteins of the spliceosomal complex. May be a
CC       constituent of a network of regulatory mechanisms that enable SR
CC       proteins to control RNA splicing and can cause redistribution of
CC       SR proteins from speckles to a diffuse nucleoplasmic distribution.
CC       Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing
CC       of tissue factor (F3) pre-mRNA in endothelial cells.
CC       {ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:9637771}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Leucettine L41 inhibits its kinase activity and
CC       affects the regulation of alternative splicing mediated by
CC       phosphorylation of SR proteins.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-745579, EBI-745579;
CC       P49760:CLK2; NbExp=12; IntAct=EBI-745579, EBI-750020;
CC       P17509:HOXB6; NbExp=5; IntAct=EBI-745579, EBI-741308;
CC       P09629:HOXB7; NbExp=5; IntAct=EBI-745579, EBI-1248457;
CC       P09017:HOXC4; NbExp=4; IntAct=EBI-745579, EBI-3923226;
CC       P29728:OAS2; NbExp=3; IntAct=EBI-745579, EBI-10211452;
CC       P38159:RBMX; NbExp=3; IntAct=EBI-745579, EBI-743526;
CC       P0DJD3:RBMY1A1; NbExp=3; IntAct=EBI-745579, EBI-8638511;
CC       Q15415:RBMY1J; NbExp=3; IntAct=EBI-745579, EBI-8642021;
CC       Q9BUV0:RSRP1; NbExp=6; IntAct=EBI-745579, EBI-745604;
CC       O00560:SDCBP; NbExp=5; IntAct=EBI-745579, EBI-727004;
CC       P78362:SRPK2; NbExp=4; IntAct=EBI-745579, EBI-593303;
CC       O43463:SUV39H1; NbExp=2; IntAct=EBI-745579, EBI-349968;
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-745579, EBI-717399;
CC       P62995:TRA2B; NbExp=3; IntAct=EBI-745579, EBI-725485;
CC       O14978:ZNF263; NbExp=3; IntAct=EBI-745579, EBI-744493;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus. Cytoplasm {ECO:0000250}.
CC       Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Nucleus speckle. Note=Co-
CC       localizes with serine- and arginine-rich (SR) proteins in the
CC       nuclear speckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=4;
CC         IsoId=P49761-4; Sequence=Displayed;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49761-1; Sequence=VSP_026138;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49761-2; Sequence=VSP_026138, VSP_004858, VSP_004859;
CC         Note=Lacks the kinase domain. May be produced at very low levels
CC         due to a premature stop codon in the mRNA, leading to
CC         nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=P49761-3; Sequence=VSP_026138, VSP_004860;
CC   -!- TISSUE SPECIFICITY: Endothelial cells.
CC       {ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Autophosphorylates on all three types of residues.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02555.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH19881.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L29220; AAA61483.1; -; mRNA.
DR   EMBL; L29217; AAA61484.1; -; mRNA.
DR   EMBL; BT006993; AAP35639.1; -; mRNA.
DR   EMBL; AC100835; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471136; EAW99321.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99322.1; -; Genomic_DNA.
DR   EMBL; BC002555; AAH02555.1; ALT_INIT; mRNA.
DR   EMBL; BC006103; AAH06103.1; -; mRNA.
DR   EMBL; BC019881; AAH19881.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10265.1; -. [P49761-1]
DR   CCDS; CCDS45304.1; -. [P49761-4]
DR   PIR; S53639; S53639.
DR   PIR; S53640; S53640.
DR   RefSeq; NP_001123500.1; NM_001130028.1. [P49761-4]
DR   RefSeq; NP_003983.2; NM_003992.4. [P49761-1]
DR   RefSeq; XP_016877398.1; XM_017021909.1. [P49761-1]
DR   RefSeq; XP_016877399.1; XM_017021910.1. [P49761-1]
DR   UniGene; Hs.511790; -.
DR   UniGene; Hs.584748; -.
DR   PDB; 2EU9; X-ray; 1.53 A; A=284-638.
DR   PDB; 2EXE; X-ray; 2.35 A; A=275-631.
DR   PDB; 2WU6; X-ray; 1.92 A; A=275-632.
DR   PDB; 2WU7; X-ray; 2.25 A; A=275-632.
DR   PDB; 3RAW; X-ray; 2.09 A; A/B=275-632.
DR   PDBsum; 2EU9; -.
DR   PDBsum; 2EXE; -.
DR   PDBsum; 2WU6; -.
DR   PDBsum; 2WU7; -.
DR   PDBsum; 3RAW; -.
DR   ProteinModelPortal; P49761; -.
DR   SMR; P49761; -.
DR   BioGrid; 107609; 93.
DR   IntAct; P49761; 63.
DR   MINT; MINT-1448658; -.
DR   STRING; 9606.ENSP00000378505; -.
DR   BindingDB; P49761; -.
DR   ChEMBL; CHEMBL4226; -.
DR   GuidetoPHARMACOLOGY; 1992; -.
DR   iPTMnet; P49761; -.
DR   PhosphoSitePlus; P49761; -.
DR   BioMuta; CLK3; -.
DR   DMDM; 148887358; -.
DR   EPD; P49761; -.
DR   PaxDb; P49761; -.
DR   PeptideAtlas; P49761; -.
DR   PRIDE; P49761; -.
DR   DNASU; 1198; -.
DR   Ensembl; ENST00000345005; ENSP00000344112; ENSG00000179335. [P49761-1]
DR   Ensembl; ENST00000395066; ENSP00000378505; ENSG00000179335. [P49761-4]
DR   Ensembl; ENST00000483723; ENSP00000431825; ENSG00000179335. [P49761-2]
DR   GeneID; 1198; -.
DR   KEGG; hsa:1198; -.
DR   UCSC; uc002ayg.4; human. [P49761-4]
DR   CTD; 1198; -.
DR   DisGeNET; 1198; -.
DR   GeneCards; CLK3; -.
DR   HGNC; HGNC:2071; CLK3.
DR   HPA; HPA046817; -.
DR   MIM; 602990; gene.
DR   neXtProt; NX_P49761; -.
DR   OpenTargets; ENSG00000179335; -.
DR   PharmGKB; PA26597; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   eggNOG; ENOG410XQF2; LUCA.
DR   GeneTree; ENSGT00580000081366; -.
DR   HOGENOM; HOG000203417; -.
DR   HOVERGEN; HBG107720; -.
DR   InParanoid; P49761; -.
DR   KO; K08823; -.
DR   OMA; NENKSCE; -.
DR   OrthoDB; EOG091G033A; -.
DR   PhylomeDB; P49761; -.
DR   TreeFam; TF101041; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   SignaLink; P49761; -.
DR   ChiTaRS; CLK3; human.
DR   EvolutionaryTrace; P49761; -.
DR   GeneWiki; CLK3_(gene); -.
DR   GenomeRNAi; 1198; -.
DR   PRO; PR:P49761; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000179335; -.
DR   CleanEx; HS_CLK3; -.
DR   ExpressionAtlas; P49761; baseline and differential.
DR   Genevisible; P49761; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Cytoplasmic vesicle; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    638       Dual specificity protein kinase CLK3.
FT                                /FTId=PRO_0000085870.
FT   DOMAIN      304    620       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     310    318       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    167    264       Arg-rich.
FT   ACT_SITE    431    431       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     334    334       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     155    155       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     197    197       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     199    199       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     215    215       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     224    224       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    148       Missing (in isoform 1, isoform 2 and
FT                                isoform 3). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7990150,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_026138.
FT   VAR_SEQ     272    300       RSQQSSKRSSRSVEDDKEGHLVCRIGDWL -> MRLWGTWV
FT                                KAPLARWWSAWTMPEGSLRLP (in isoform 2).
FT                                {ECO:0000303|PubMed:7990150}.
FT                                /FTId=VSP_004858.
FT   VAR_SEQ     301    638       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7990150}.
FT                                /FTId=VSP_004859.
FT   VAR_SEQ     306    328       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_004860.
FT   VARIANT     486    486       R -> C. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040413.
FT   VARIANT     607    607       Q -> R. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045579.
FT   VARIANT     628    628       R -> W. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045580.
FT   CONFLICT    280    281       SS -> TG (in Ref. 1; AAA61484).
FT                                {ECO:0000305}.
FT   TURN        301    303       {ECO:0000244|PDB:2EU9}.
FT   STRAND      304    313       {ECO:0000244|PDB:2EU9}.
FT   STRAND      316    323       {ECO:0000244|PDB:2EU9}.
FT   TURN        324    328       {ECO:0000244|PDB:2EU9}.
FT   STRAND      330    336       {ECO:0000244|PDB:2EU9}.
FT   HELIX       340    359       {ECO:0000244|PDB:2EU9}.
FT   STRAND      370    376       {ECO:0000244|PDB:2EU9}.
FT   STRAND      379    385       {ECO:0000244|PDB:2EU9}.
FT   HELIX       391    397       {ECO:0000244|PDB:2EU9}.
FT   TURN        398    400       {ECO:0000244|PDB:2EU9}.
FT   HELIX       405    423       {ECO:0000244|PDB:2EU9}.
FT   TURN        424    426       {ECO:0000244|PDB:2EU9}.
FT   HELIX       434    436       {ECO:0000244|PDB:2EU9}.
FT   STRAND      437    440       {ECO:0000244|PDB:2EU9}.
FT   STRAND      444    448       {ECO:0000244|PDB:2EU9}.
FT   TURN        450    453       {ECO:0000244|PDB:2WU6}.
FT   STRAND      456    460       {ECO:0000244|PDB:2EU9}.
FT   STRAND      464    466       {ECO:0000244|PDB:2EU9}.
FT   HELIX       469    471       {ECO:0000244|PDB:2EXE}.
FT   HELIX       486    488       {ECO:0000244|PDB:2EU9}.
FT   HELIX       491    494       {ECO:0000244|PDB:2EU9}.
FT   HELIX       502    517       {ECO:0000244|PDB:2EU9}.
FT   HELIX       527    538       {ECO:0000244|PDB:2EU9}.
FT   HELIX       543    548       {ECO:0000244|PDB:2EU9}.
FT   HELIX       552    554       {ECO:0000244|PDB:2EU9}.
FT   HELIX       567    575       {ECO:0000244|PDB:2EU9}.
FT   HELIX       579    582       {ECO:0000244|PDB:2EU9}.
FT   HELIX       588    600       {ECO:0000244|PDB:2EU9}.
FT   TURN        605    607       {ECO:0000244|PDB:2EU9}.
FT   HELIX       611    614       {ECO:0000244|PDB:2EU9}.
FT   HELIX       618    622       {ECO:0000244|PDB:2EU9}.
FT   HELIX       625    628       {ECO:0000244|PDB:2EU9}.
SQ   SEQUENCE   638 AA;  73515 MW;  D3B60A9DB4ECEC94 CRC64;
     MPVLSARRRE LADHAGSGRR SGPSPTARSG PHLSALRAQP ARAAHLSGRG TYVRRDTAGG
     GPGQARPLGP PGTSLLGRGA RRSGEGWCPG AFESGARAAR PPSRVEPRLA TAASREGAGL
     PRAEVAAGSG RGARSGEWGL AAAGAWETMH HCKRYRSPEP DPYLSYRWKR RRSYSREHEG
     RLRYPSRREP PPRRSRSRSH DRLPYQRRYR ERRDSDTYRC EERSPSFGED YYGPSRSRHR
     RRSRERGPYR TRKHAHHCHK RRTRSCSSAS SRSQQSSKRS SRSVEDDKEG HLVCRIGDWL
     QERYEIVGNL GEGTFGKVVE CLDHARGKSQ VALKIIRNVG KYREAARLEI NVLKKIKEKD
     KENKFLCVLM SDWFNFHGHM CIAFELLGKN TFEFLKENNF QPYPLPHVRH MAYQLCHALR
     FLHENQLTHT DLKPENILFV NSEFETLYNE HKSCEEKSVK NTSIRVADFG SATFDHEHHT
     TIVATRHYRP PEVILELGWA QPCDVWSIGC ILFEYYRGFT LFQTHENREH LVMMEKILGP
     IPSHMIHRTR KQKYFYKGGL VWDENSSDGR YVKENCKPLK SYMLQDSLEH VQLFDLMRRM
     LEFDPAQRIT LAEALLHPFF AGLTPEERSF HTSRNPSR
//
